Jim Cunniff

President & Chief Executive Officer

Therapeutic Areas

Drug	Indication	Phase
SmartVest Clearway System	Bronchiectasis, COPD, Impaired Airway Clearance	Commercial
Next-Generation Product Development	Platform Enhancements	R&D
Clinical Evidence Expansion	Bronchiectasis, COPD, Post-COVID Sequelae	Evidence Generation